SavedAdd your journal

Journals / Medical Network Klinik Bilimler ve Doktor / 2003 / Cilt: 9 - Sayı: 1

Topical clindamycin cream application in the treatment of bacterial vaginosis

Bakteriyel vajinozis tedavisinde topikal klindamisin krem

Tayfun GÜNGÖR
Süleyman ESERDAĞ
Pages
91–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It was observed in this study that the topical clindamycin application can take part in the treatment alternatives of bacterial vaginosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Bacterial vaginosis is one of the basic reasons of vaginitis.
📊
Key Findings & Data:Material and Method: In this study, the effect of Cleocin® 2% vaginal cream on bacterial vaginosis was searched.
💡
Conclusion & Impact:Conclusion: It was observed in this study that the topical clindamycin application can take part in the treatment alternatives of bacterial vaginosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Vajinoz · bakteriyel · İlaç uygulama

Abstract

Objective: Bacterial vaginosis is one of the basic reasons of vaginitis. It's relation to pelvic inflammatory disease and it's leading to worse obstetric prognosis are serious reasons of morbidity. The aim of this study was to search the effectivity of topical clindamycin application as an alternative to oral antibiotics in the treatment of Bacterial vaginosis. Material and Method: In this study, the effect of Cleocin® 2% vaginal cream on bacterial vaginosis was searched. In our study, 66 of 70 participating patients to the gynecology outpatient service of Zekai Tahir Burak Maternity Hospital have completed this research. Results: On the results of 14. and 21. day controls, 60 of 66 patients (91%) were microbiologically and 62 of them (94%) were clinically cured. Conclusion: It was observed in this study that the topical clindamycin application can take part in the treatment alternatives of bacterial vaginosis.

Özet

Amaç: Bakteriyel vajinozis (BV) vajinitin en temel nedenlerinden birisidir. Pelvik inflamatuar hastalık (PID) ile olan ilişkisi ve kötü obstetrik prognoza sebep olması ciddi morbidite nedenleridir. Bu çalışmamızdaki amaç; BV tedavisinde oral antibiyotik kullanımlarına bir alternatif olarak, topikal klindamisin kullanımının tedavideki etkinliğini araştırmaktı. Gereç ve Yöntem: Bu çalışmada Cleosin® %2 gr vajinal kremin BV üzerindeki etkinliği araştırıldı. Çalışmamızda, Zekai Tahir Burak Kadın Sağlığı Hastanesi Jinekoloji polikliniğine başvuran 70 hastadan 66'sı araştırmayı tamamladı. Bulgular: 14. ve 21. günlerde yapılan kontroller sonucunda 66 hastadan 60'ında (%91) mikrobiyolojik olarak, 62'sinde ise (%94) klinik olarak tedavi edilmiştir. Sonuç: Topikal klindamisin krem uygulamasının BV tedavisinde tedavi seçenekleri arasında yer alabileceği bu çalışmada görülmüştür.

🔖

Cite This Article

GÜNGÖR, T., ESERDAĞ, S. (2003). Topical clindamycin cream application in the treatment of bacterial vaginosis. Medical Network Klinik Bilimler ve Doktor, Cilt: 9 - Sayı: 1, 91–93. https://ajindex.com/articles/278493

References (13)

  1. Kurki T, Sevoner A, Renkonen OV. Bakterial vaginosis in jnancy and pregnancy outcome Obstet Gynecol 1992; 173-7. Majenori MA. Am. Fam. Physician. Bacterial Vaginosis 1998; 1285-91.
  2. Priestley CJ, Kinghom GR. Bacteriel vaginosis. Br. J. Clin pract. 1996; 50:331-4.
  3. Mikamo H. Kawazoe K, İzumi K. Bacteriological epidemiology and treatment of bacterial vaginosis. Chemotherapy 1996; 42:78-84.
  4. Pheifer TA. Forsyth PS, Durfee MA. Nonspecific vaginitis: role of Hemophilus vaginalis and treatment with metronidazole N. Engl. J. Med. 1978; 298:1429-34.
  5. McCoy MC, Katz VL, Küller JA. Bacteriel vaginosis in pregnancy Obstet Gynecol Surv. 1995; 50:482-8.
  6. Amsel R, Tolter PA, Spiegel CA. Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations. Am.J. Med. 1983; 74:14-22. Nelson MS. Clinical diagnosis of bacterial vaginosis. Am. J. Emerg Med 1987; 5:488-9.
  7. Ferris-DG, Litaker MS, Woodward-L, Mathis D. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel and clindamycin vaginal cream. J. Fam-Pract. 1995; 41:443-9. Mohanty RC. Bacterial vaginosis. Br. J. Sex Med. 1991; 18:38-9.
  8. Blackwell Al, Fox AR, Philips I, Barlow D. Anaerobic vaginosis. Clinical, mikrobiolologicai and therapeutic findings Lancet ii: 1983; 19:79-83.
  9. Malouf M, Fortier M, Morin G. Treatment of Hemophilus vaginalis vaginitis Obstet Gynecol 1981; 54:711-4.
  10. Singha HSK, Deventra SV. Local therapy for bacterial vaginosis. Br. J. Sex Med 1981; 16:235-40. Fleury FJ. Recurrent Candida Vulvovaginitis. Chemotherapy 28 suppl 1982; 1:48-50.
  11. Peeters F, Snawaert R Van. (utsen) A controlled trial with miconazole in the prevention of yeast infections occuring after treatment of vaginal tricomonas. Eur. J. Obstet Gynecol Repord Biol 1974; 4:94-9. Sobel JA. Vaginal infections in adult women. Med Clin North Am. 1990; 74:1573-602. Centers for Disease Control Sexually transmitted diseases treatment guidelines MMWR 1989; 38:36-7.
  12. Battaglia F, Scambia G, De Vincenzo R. Therapy of bacterial vaginosis. Minerva Gynecol 1998; 50:109-19.
  13. Joesoef MR, Hillier SL, Wiknjosastro G. introvaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight Am. J. Obstet Gynecol 1995; 173:1527-31. Ahmed Jushuf Shahmanesh M. Arya Op. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream. Genitourin-Med. 1995; 71:254-6. Greaves WL. Chungafungs Morris B. Clindamycin versus metronidazole in the treatment of bacterial